​​​​​Benefits for Authors

HemaSphere is an international open access journal. Distinct benefits and features of HemaSphere include:

• 2022 Journal Impact Factor (preliminary): 6.6 (source: Clarivate Analytics. Final JIFs expected September/October, 2023.)
• Open access and fully indexed in PubMed Central​
• Rigorous peer review guided by an expert Editorial Board
• Fast publication
• Low publication fees
• Authors/funders retain copyright
• Forum for publicly funded research
• ​​EHA members can publish their work at a discounted rate for a limited period